Enoxaparin treatment in women with mechanical heart valves during pregnancy

American Journal of Obstetrics and Gynecology

Volumn 185, Issue 3, 2001, Pages 633-637

  Rowan, Janet A ^a,b   McCowan, Lesley M E ^a,b   Raudkivi, Peter J ^a,b   North, Robyn A ^a,b  

^a NATIONAL WOMEN S HOSPITAL   (New Zealand)

^b Green Lane Hospital   (New Zealand)

Author keywords

Anticoagulation; Low molecular weight heparin; Mechanical heart valves; Pregnancy

Indexed keywords

ACETYLSALICYLIC ACID; BLOOD CLOTTING FACTOR 10A; ENOXAPARIN; LOW MOLECULAR WEIGHT HEPARIN;

ADULT; ANTICOAGULATION; ARTICLE; CLINICAL ARTICLE; HEART VALVE PROSTHESIS; HUMAN; PATIENT MONITORING; PRACTICE GUIDELINE; PRIORITY JOURNAL; THROMBOSIS; THROMBOSIS PREVENTION;

EID: 0034822068     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1067/mob.2001.117657     Document Type: Article

References (11)

1. Anticoagulation of pregnant women with mechanical heart valves: A systematic review of the literature
2. Anticoagulation in pregnant women with mechanical heart valve prostheses
3. Dose-dependent fetal complications of warfarin in pregnant women with mechanical heart valves
4. Pregnancy outcomes and cardiac complications in women with mechanical, bioprosthetic and homograft valves
5. Use of antithrombotic agents during pregnancy
6. Pregnancy through a prosthetic heart valve
7. Low-molecular-weight heparins
8. Use of low molecular weight heparin in pregnancy
9. Low molecular weight heparin for thromboprophylaxis during pregnancy in 2 patients with mechanical mitral valve replacement
10. Is there a safe anticoagulation protocol for pregnant women with prosthetic valves?
11. Long-term survival and valve-related complications in young women with cardiac valve replacements